Health Care Select Sector SPDR® ETF (XLV)

Add to Watchlists
Create an Alert
74.73 +0.32  +0.43% NYSE Arca Apr 25, 20:00 Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Key Stats

Expense Ratio 0.14%
Share Class Assets Under Management 15.82B
30-Day Average Daily Volume Upgrade
Net Asset Value 74.75
Discount or Premium to NAV -0.02%
Turnover Ratio 8.00

XLV Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 0.59% 0.62% 90
3M 7.58% 9.07% 85
6M 8.58% 9.45% 80
1Y 11.47% 6.37% 62
3Y 9.95% 9.57% 51
5Y 16.47% 16.63% 52
As of April 25, 2017
Returns for periods of 1 year and above are annualized.

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.15% 0.15% 0.00
Stock 99.85% 99.85% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of April 24, 2017

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of April 24, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.39%
Industrials 0.00
Real Estate 0.00
Technology 0.61%
Utilities 0.00
As of April 24, 2017

XLV Stock Market Capitalization

Giant 52.07%
Large 37.77%
Medium 10.16%
Small 0.00
Micro 0.00
As of April 24, 2017

XLV Stock Style Exposure

Large Cap Value 37.18%
Large Cap Blend 14.16%
Large Cap Growth 38.50%
Mid Cap Value 1.26%
Mid Cap Blend 3.73%
Mid Cap Growth 5.18%
Small Cap Value 0.00
Small Cap Blend 0.00
Small Cap Growth 0.00
As of April 24, 2017
View More Holdings

XLV Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 11.77% 123.43 +0.44%
PFE Pfizer Inc 7.09% 33.76 +0.06%
MRK Merck & Co Inc 6.02% 62.30 +0.26%
UNH UnitedHealth Group Inc 5.90% 174.04 +0.99%
AMGN Amgen Inc 4.24% 164.70 +0.96%
MDT Medtronic PLC 3.91% 81.76 +1.38%
ABBV AbbVie Inc 3.64% 65.10 +0.68%
CELG Celgene Corp 3.38% 125.52 +1.92%
BMY Bristol-Myers Squibb Company 3.18% 53.94 +0.73%
GILD Gilead Sciences Inc 3.06% 67.12 +1.31%
As of April 24, 2017
Advertisement

XLV One Page Reports

XLV Basic Info

Style
Equity Style Large Cap/Blend
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD
100.0%

XLV Manager Info

Name Tenure
Dwayne Hancock 0.24 yrs
Karl Schneider 2.17 yrs
Michael Feehily 6.17 yrs

XLV Net Fund Flows

1M -115.60M
3M 1.223B
6M 2.891B
YTD 1.223B
1Y 2.936B
3Y 3.902B
5Y 6.229B
10Y 8.054B
As of March 31, 2017

XLV Risk Info

Beta (5Y) 0.8659
Max Drawdown (All) 40.58%
Historical Sharpe (10Y) 0.7615
Historical Sortino (All) 0.6829
30-Day Rolling Volatility 8.01%
Daily Value at Risk (VaR) 1% (All) 3.04%
Monthly Value at Risk (VaR) 1% (All) 13.48%

XLV Fundamentals

Dividend Yield TTM (4-25-17) 1.53%
SEC Yield (4-24-17) 1.54%
Weighted Average PE Ratio 22.64
Weighted Average Price to Sales Ratio 1.786
Weighted Average Price to Book Ratio 3.713
Weighted Median ROE 22.53%
Weighted Median ROA 8.18%
Forecasted Dividend Yield 1.79%
Forecasted PE Ratio 19.26
Forecasted Price to Sales Ratio 1.626
Forecasted Price to Book Ratio 3.139
Number of Holdings 62
As of April 24, 2017

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 8.82%
Forecasted Book Value Growth 9.09%
Forecasted Cash Flow Growth 14.57%
Forecasted Earnings Growth 10.29%
Forecasted Revenue Growth 9.91%
As of April 24, 2017

XLV Comparables

Edit

XLV Attributes

Key Dates
Inception Date 12/16/1998
Last Annual Report Date 9/30/2016
Last Prospectus Date 1/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XLV Excel Add-In Codes

  • Name: =YCI("XLV","name")
  • Broad Asset Class: =YCI("XLV", "broad_asset_class")
  • Broad Category: =YCI("XLV", "broad_category_group")
  • Prospectus Objective: =YCI("XLV", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.